Host: Hallie Blevins, PhD. Early resistance to hydroxyurea in patients with polycythemia vera (PV) is associated with higher risks of thromboembolic complications, disease progression, and mortality. The PV-AIM study applied machine learning to real-world data and identified simple lab-based predictors that stratify patients by risk, and these findings were later validated in the HU-F-AIM trial. Hear from ReachMD's Dr. Hallie Blevins as she dives into the results and explains

Host: Ryan Quigley A new multicenter study highlights how serum and CSF biomarkers can refine prognostic accuracy and guide treatment strategies in multiple sclerosis (MS). ReachMD's Ryan Quigley explains key findings and provides insights on how integrating these biomarkers at diagnosis could move MS care toward more personalized and effective interventions. This topic was also discussed at the 2025 Congress of the European Committee for Treatment and Research in Multiple Sclerosis

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Kwo, MD While sometimes overlooked, minimally elevated liver tests may signal early liver disease or non-hepatic conditions like thyroid dysfunction. As a result, interpreting ALT and AST thresholds, assessing metabolic risk, and reviewing lifestyle factors can help shape a focused diagnostic approach and reduce liver-related complications. Joining Dr. Peter Buch to provide insights into the evaluation of minimally elevated liver

Neuroanatomy Music ‘Today’ by Dan Brodbeck and Corey Thompson

Dr. Barry Dworkin opens the phone lines and takes your health-related questions on the CFRA textboard.

Join us for a focused webinar showcasing the Type Influenza Strain workflow within QIAGEN CLC Genomics Workbench. This streamlined, template-based workflow enables efficient typing of targeted Influenza virus sequencing data by integrating consensus sequence refinement, reference-based subtype identification and mixed-infection variant detection.We’ll show how the workflow:Automatically determines Influenza virus type and subtypeOutputs annotated consensus sequences with gene and CDS tracks for

*Evolution 2025!Fred Williams welcomes creation scientist Sal Cordova, fresh from presenting at the world’s leading evolution conference. *Most Viewed Presentation!Hear how Sal’s talk on redefining “fitness” and exposing genetic decay became the #1 concurrent session video on the conference’s official YouTube channel. *Biology Outpaces Technology: More fun Quantumness - Discover how quantum compasses in birds, photon-sensing eyes, and molecular machines surpass human

Eye On The Night Sky For Monday, September 15

Dr. Karen Daniels is a Professor in the Department of Physics at North Carolina State University. Karen’s lab investigates the physics of how materials change state (e.g. from solid to fluid), how they deform, and how they may ultimately fail. She studies these questions across a variety of length and time scales, from microscopic phenomena that occur in less than a second to shifts in land that occur on geologic timescales and may lead to landslides. Travel is a passion for Karen. While traveling,

#268: Dr. Michelle Dulake — the practicing veterinarian who co-founded Fera Pets supplements and devises all the formulations — talks about how she created feline supplements to address the special and specific health needs of cats, from immune system support to kidney disease.

Fueling Creativity and Innovation: A Chat About What Really Sparks Our Best Ideas

Host: Marlene Mimi Maeusli, PhD. A recent Danish population-based study evaluating real-world outcomes of ibrutinib in relapsed or refractory mantle cell lymphoma (MCL) found lower efficacy and tolerability compared to clinical trials, particularly among older patients and those with high-risk disease features. In this AudioAbstract, ReachMD's Dr. Mimi Maeusli explains how this evidence is reshaping our view of ibrutinib's clinical utility.

Moderator: Gerard A. Silvestri MD, MS, Master FCCP Guest: Jessica S. Donington, MD, MSCR Guest: Mariam Alexander, MD, PhD Guest: Anurag Singh, MD Effective care for non-small cell lung cancer (NSCLC) now depends on early molecular testing and coordinated input from a variety of specialties. Dr. Gerard Silvestri sits down with Drs. Jessica Donington, Mariam Alexander, and Anurag Singh to review why multidisciplinary integration is critical to avoid treatment delays, ensure

Moderator: Gerard A. Silvestri MD, MS, Master FCCP Guest: Jessica S. Donington, MD, MSCR Guest: Mariam Alexander, MD, PhD Guest: Anurag Singh, MD Recent data from ASCO and ASTRO 2025 are redefining standards of care for resectable non-small cell lung cancer (NSCLC). Drs. Gerard Silvestri, Mariam Alexander, Anurag Singh, and Jessica Donington review these updates on the importance of molecular testing, careful surgical selection, and multidisciplinary planning to optimize

Host: Ryan Quigley In relapsed or refractory follicular lymphoma, disease control is only part of the equation. In this AudioAbstract, ReachMD's Ryan Quigley explores patient-reported outcomes from the ELM-2 trial, revealing that odronextamab not only delivers high response rates but also helps preserve—and in some cases, improve—quality of life.

Nuevo capítulo del podcast "Desde el sur: explorando el Cosmos".Programa 564Tratamos los siguientes temas:- Entrevistamos a la Dra. Ximena Abrevaya, Astrobióloga argentina yfrecuente colaboradora de nuestro programa, y hablamos sobre la actualidaden exobiología y otros temas.La entrevista fue realizada antes del anuncio de la NASA del hallazgo de biomarcadores en Marte, así que la volvimos a consultar sobre este tema, esa entrevista la encontrarán en:

How did we get here? Music 'Today' by Dan Brodbeck and Corey Thompson

IPA is more than just an analysis program; it can also help you write grants and publications. IPA provides biological insights backed by expert-curated findings and thousands of pre-analyzed multi-omics datasets. You can search for existing knowledge on molecules of interest, build networks and review results from public studies. Or you can identify key pathways, regulatory molecules and functional changes in your results and see how your data relates to published studies.You'll learn how to:•

This webinar will focus on running the fusion detection analysis within QIAGEN CLC Genomics Workbench and annotating the detected fusions using curated clinical knowledge from Human Somatic Mutation Database (HSMD). Finally, the data will be uploaded to QIAGEN Clinical Insight (QCI) applications for further analysis.You will learn:• How fusion detection algorithms work• To run the fusion detection template workflow• To interpret the analysis results• To annotate fusions with HSMD• To upload and

Clint Eastwood at the 2012 Republican National Convention - WikipediaFood Safety Talk 11: Somewhere on I-95 — Food Safety TalkFreshRealm Recalls Chicken Fettuccine Alfredo Products Due to Possible Listeria Contamination | Food Safety and Inspection ServiceListeria Outbreak Linked to Chicken Fettuccine Alfredo Meals | Listeria Infection | CDCWhen People Got Sick: Chicken Fettuccine Alfredo Meals Outbreak, June 2025 | Listeria Infection | CDCOutbreak Investigation of Listeria monocytogenes: Chicken